title: Haemolysis during sample preparation alters microRNA content of plasma.
abstract: The presence of cell-free microRNAs (miRNAs) has been detected in a range of body fluids. The miRNA content of plasma/serum in particular has been proposed as a potential source of novel biomarkers for a number of diseases. Nevertheless, the quantification of miRNAs from plasma or serum is made difficult due to inefficient isolation and lack of consensus regarding the optimal reference miRNA. The effect of haemolysis on the quantification and normalisation of miRNAs in plasma has not been investigated in great detail. We found that levels of miR-16, a commonly used reference gene, showed little variation when measured in plasma samples from healthy volunteers or patients with malignant mesothelioma or coronary artery disease. Including samples with evidence of haemolysis led to variation in miR-16 levels and consequently decreased its ability to serve as a reference. The levels of miR-16 and miR-451, both present in significant levels in red blood cells, were proportional to the degree of haemolysis. Measurements of the level of these miRNAs in whole blood, plasma, red blood cells and peripheral blood mononuclear cells revealed that the miRNA content of red blood cells represents the major source of variation in miR-16 and miR-451 levels measured in plasma. Adding lysed red blood cells to non-haemolysed plasma allowed a cut-off level of free haemoglobin to be determined, below which miR-16 and miR-451 levels displayed little variation between individuals. In conclusion, increases in plasma miR-16 and miR-451 are caused by haemolysis. In the absence of haemolysis the levels of both miR-16 and miR-451 are sufficiently constant to serve as normalisers.
authors: Asbestos Diseases Research Institute, Bernie Banton Centre, University of Sydney, Sydney, Australia.
authors: Michaela B
authors: MB
authors: Kirschner
authors: Steven C
authors: SC
authors: Kao
authors: J James
authors: JJ
authors: Edelman
authors: Nicola J
authors: NJ
authors: Armstrong
authors: Michael P
authors: MP
authors: Vallely
authors: Nico
authors: N
authors: van Zandwijk
authors: Glen
authors: G
authors: Reid
mesh_terms: D015415:Biomarkers / Q000097:blood; D001800:Blood Specimen Collection / Q000379:methods*; D003324:Coronary Artery Disease / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006461:Hemolysis / Q000502:physiology*; D006801:Humans; D008654:Mesothelioma / Q000097:blood; D035683:MicroRNAs / Q000097:blood*
chemical_list: D015415:Biomarkers; D006454:Hemoglobins; C505362:MIRN16 microRNA, human; C531201:MIRN451 microRNA, human; D035683:MicroRNAs